Cargando…
AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats
BACKGROUND: To evaluate the AMP-activated protein kinase- (AMPK-) mediated signaling and NF-κB-related inflammatory pathways that contribute to cholestatic diseases in the bile duct ligation (BDL) rat model of chronic cholestasis and verify the protective role of 5-Aminoimidazole-4-carboxamide1-β-D-...
Autores principales: | Zhu, Haoyang, Chai, Yichao, Dong, Dinghui, Zhang, Nana, Liu, Wenyan, Ma, Tao, Wu, Rongqian, Lv, Yi, Hu, Liangshuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314002/ https://www.ncbi.nlm.nih.gov/pubmed/30662889 http://dx.doi.org/10.1155/2018/6181432 |
Ejemplares similares
-
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model
por: Hu, Liangshuo, et al.
Publicado: (2019) -
AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages
por: Kirchner, Johannes, et al.
Publicado: (2018) -
A Novel Remote-Controlled Injection Device for T-Tube Cholangiography: A Feasibility Study in Canines
por: Zhu, Haoyang, et al.
Publicado: (2019) -
Noncanonical NF-κB in Cancer
por: Tegowski, Matthew, et al.
Publicado: (2018) -
AMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
por: Rae, Colin, et al.
Publicado: (2019)